| Dominant | Subordinate |
| ||
Immune traits | Baseline (d30) | 24-h (d31) | Baseline (d30) | 24-h (d31) | P-value |
Total WBC, 107/10mL | 2.6 ± 0.10 | 2.1 ± 0.11 | 2.7 ± 0.11a | 2.0 ± 0.12b | 0.05 |
Neutrophils, 107/mL | 5.7 ± 0.63 | 5.9 ± 0.63 | 5.7± 0.61 | 6.4 ± 0.61 | 0.77 |
Lymphocytes, 107/mL | 2.7 ± 0.28 | 3.1 ± 0.28 | 2.6 ± 0.28a | 3.3 ± 0.28b | 0.09 |
Neutrophils, % | 31.6 ± 3.1a | 40.0 ± 3.1b | 32.6 ± 3.0a | 40.5 ± 3.0b | 0.07 |
Lymphocytes, % | 60.4 ± 2.3 | 52.8 ± 2.3 | 58.8 ± 2.2 | 51.8 ± 3.2 | 0.10 |
Monocytes, % | 3.8 ± 0.4 | 2.4 ± 0.4 | 3.7 ± 0.6 | 3.5 ± 0.6 | 0.78 |
Eosinophils, % | 4.3 ± 0.5 | 4.9 ± 0.5 | 5.0 ± 0.3 | 4.8 ± 0.3 | 0.57 |
Neutrophil-to-lymphocyte ratio | 0.55 ± 0.26 | 1.03 ± 0.26 | 0.58 ± 0.26 | 0.92 ± 0.26 | 0.72 |
LPS-induced proliferation | 1.3 ± 0.20a | 0.92 ± 0.18b | 1.7 ± 0.19 | 1.3 ± 0.20 | 0.05 |
ConA-induced proliferation | 1.3 ± 0.4a | 2.5 ± 0.4b | 1.6 ± 0.4 | 2.6 ± 0.4 | 0.06 |
NK cytotoxicity, % | 60.9 ± 15 | 56.9 ± 15 | 49.8 ± 15 | 62.8 ± 15 | 0.74 |
Chemotaxis, IL-8 | 39.4 ± 16 | 54.2 ± 15 | 29.5 ± 18a | 92.6 ± 15b | < 0.001 |
Chemotaxis, C5a | 34.1 ± 8.1 | 68.8 ± 6.1 | 38.2 ± 8.1 | 60.4 ± 6.1 | 0.37 |
Plasma cortisol, ng/mL | 28.9 ± 2.2 | 29.0 ± 2.2 | 30.9 ± 2.3 | 29.0 ± 2.3 | 0.85 |